MGX compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

MGXMetagenomi Therapeutics, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

MGXMetagenomi Therapeutics, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MGX: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

MGX, solidAMGN, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MGX 2

IONSIonis Pharmaceuticalscustomer

—Acuitas Therapeuticsunlistedsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

MGXMetagenomi Therapeutics, Inc.

0.71▼−3.12%· post 0.71· delayed

Mkt cap$27.6MRevenue$1MQ1 FY26Revenue$25MFY25

AMGNAmgen Inc

460.55▲+0.06%· post 460.13· delayed

After hoursNov 6 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

After hoursNov 6 '26delayed

MGXMetagenomi Therapeutics, Inc.

AMGNAmgen Inc

0.71▼−3.12%post 0.71delayed

Price

460.55▲+0.06%post 460.13delayed

$27.6M

Mkt cap

$249.0B

Q1 FY26$1M

Revenue

$10.4BQ3 FY26

FY25$25M

Revenue

$36.8BFY25

MGX0.71▼−3.12%vsAMGN460.55▲+0.06%After hoursNov 6 '26delayed